Skip to main content
Clinical Trials/NCT05622045
NCT05622045
Active, not recruiting
Not Applicable

Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)

Loma Linda University1 site in 1 country59 target enrollmentFebruary 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Loma Linda University
Enrollment
59
Locations
1
Primary Endpoint
Predicated patient physical activity level
Status
Active, not recruiting
Last Updated
8 months ago

Overview

Brief Summary

The goal of this observational study is to learn about the personality attributes and values of people living with obesity that are part of the Latino community, and how these personality attributes and values can help to predict success during a weight loss program.

The main questions it aims to answer are:

  • What are the personality attributes and values of people living with obesity that sign up to the LCSS-Latino Crossover Semaglutide Study trial?
  • Can behavioral artificial intelligence (a computer formula) predict which patients will complete the LCSS-Latino Crossover Semaglutide Study trial?
  • How do behavioral artificial Intelligence predictions (a computer formula) compare to clinician predictions of patient success?
  • Can behavioral artificial intelligence (a computer formula) predict patient weight loss, calorie consumption and physical activity levels during the LCSS-Latino Crossover Semaglutide Study trial? Participants will be recorded in English and Spanish while responding to a question regarding participation in a weight loss study.
Registry
clinicaltrials.gov
Start Date
February 1, 2023
End Date
May 1, 2026
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participation in the LCSS-Latino Crossover Semaglutide Study

Exclusion Criteria

  • Not a participant of the LCSS-Latino Crossover Semaglutide Study at the point of data collection

Outcomes

Primary Outcomes

Predicated patient physical activity level

Time Frame: The voice data measurement will take at baseline and take about 10-15 minutes for collection to take place.

Predicted patient physical activity level as determined by Scaled Insights Behavioural Artificial Intelligence based on subject voice data. Predicted physical activity will be compared to the physical activity measured in a separate clinical trial \[Latino Crossover Semaglutide Study (LCSS) NCT05087342\]. Similar physical activity level values between the predicted and measured outcomes will indicate that the Scaled Insights Behavioural Artificial Intelligence is good predictor.

Predicted patient weight change success

Time Frame: The voice data measurement will take place at baseline and take about 10-15 minutes for collection to take place.

Predicted patient weight change as determined by Scaled Insights Behavioural Artificial Intelligence based on subject voice data. Weight loss exceeding 5-10 pounds over 6 months will be considered to be successful. Predicted weight change will be compared to the weight change measured in a separate clinical trial \[Latino Crossover Semaglutide Study (LCSS) NCT05087342\]. Similar weight change values between the predicted and measured outcomes will indicate that the Scaled Insights Behavioural Artificial Intelligence is good predictor.

Clinician predictions

Time Frame: The clinician judgement will be measured during the second month of the subject's weight loss study.

Clinician (physician) judgement of patient weight loss success during a weight loss study.

Predicated patient calorie intake

Time Frame: The voice data measurement will take place during the subject's initial clinic visit and take about 10-15 minutes for collection to take place.

Predicted patient calorie intake as determined by Scaled Insights Behavioural Artificial Intelligence based on subject voice data. Predicted calorie intake will be compared to the calorie intake measured in a separate clinical trial \[Latino Crossover Semaglutide Study (LCSS) NCT05087342\]. Similar calorie values between the predicted and measured outcomes will indicate that the Scaled Insights Behavioural Artificial Intelligence is good predictor.

Secondary Outcomes

  • Personality attributes and values(The voice data measurement will take place at baseline and take about 10-15 minutes for collection to take place.)
  • Predicted patient attrition rate(The voice data measurement will take place at baseline and take about 10-15 minutes for collection to take place.)

Study Sites (1)

Loading locations...

Similar Trials